SentiAR

Key People

• Berk Tas - CEO
  Email: [emailprotected]
• Dr. Jennifer Silva - Chief Medical Officer
• Jonathan Silva, PhD - Chief Technology Officer
• Michael Southworth - Co-Founder

Assessment

Team

Aspect: First-time physician innovator
Summary: The leadership team includes experienced professionals with backgrounds in medicine and technology.

The team comprises individuals with significant expertise in their respective fields, contributing to the company's innovative approach in medical device development.

Clinical Need

Aspect: Very Strong
Summary: SentiAR addresses a critical need in interventional cardiology by enhancing visualization during procedures.

The company's technology offers a significant improvement in procedural accuracy and efficiency, meeting a substantial clinical demand.

Competition

Aspect: First mover
Summary: SentiAR is pioneering augmented reality applications in interventional procedures.

As an early entrant in this niche market, SentiAR has the advantage of establishing itself as a leader before competitors emerge.

Technical Challenge

Aspect: Complex
Summary: Developing real-time 3D holographic interfaces for medical procedures involves significant technical complexity.

The integration of augmented reality with existing medical imaging systems presents substantial technical challenges that must be addressed for successful implementation.

Patent

Aspect: Strong
Summary: SentiAR has secured patents to protect its innovative technology.

The company's intellectual property portfolio provides a competitive edge and safeguards its technological advancements.

Financing

Aspect: Well-funded
Summary: SentiAR has successfully raised significant funding, including an $8.5 million Series B round.

The substantial financial backing enables the company to expand partnerships and clinical deployments, supporting its growth objectives.

Regulatory

Aspect: 510k/PMA
Summary: SentiAR has achieved FDA 510(k) clearance for its CommandEP system.

Obtaining regulatory approval is a critical milestone that facilitates market entry and adoption of the technology.

Opportunity Rollup

Odds of Success

4

Peak Market Share

5.85

Segment CAGR

4.5%

Market Segment

Electrophysiology Devices

Market Sub Segment

Augmented Reality Visualization Systems

Key Takeaway

SentiAR's innovative AR technology addresses a significant clinical need in interventional cardiology, supported by a strong team and substantial funding, positioning it well for market success.